Form 4: Integra LifeSciences CFO Disposes of Shares for Tax Obligations

Integra LifeSciences Holdings Corp's Executive Vice President and Chief Financial Officer, Lea Daniels Knight, disposed of 2,561 shares of common stock to cover tax withholding obligations.

Summary

• Lea Daniels Knight, Executive Vice President and Chief Financial Officer of Integra LifeSciences Holdings Corp (IART), disposed of 2,561 shares of common stock.
• The transaction occurred on July 3, 2025, at a price of $13.49 per share.
• This disposition was coded as 'F', indicating it was to satisfy tax withholding obligations related to equity compensation.
• Following this transaction, Lea Daniels Knight beneficially owns 58,578 shares of Integra LifeSciences common stock.

Sentiment

Score: 5

Explanation: The document reports a routine, expected transaction (disposition for tax withholding) by an executive, which is neutral in sentiment and does not indicate positive or negative company performance.

Positives

• The transaction is a routine disposition for tax withholding, which is a common occurrence when executive equity awards vest, indicating the fulfillment of compensation plans.

Negatives

• No specific negative aspects are indicated by this routine tax-related transaction.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the general nature of equity ownership.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The transaction was executed by Lea Daniels Knight, EVP & Chief Financial Officer, indicating a routine part of executive compensation and tax planning.

Industry Context

This Form 4 filing details a routine insider transaction (disposition for tax withholding) and does not provide broader industry context or trends. Such transactions are common across all publicly traded companies when executive equity awards vest.

Comparison to Industry Standards

• This Form 4 filing is a standard disclosure of an insider stock transaction for tax purposes. It does not contain information that allows for a direct comparison of company performance or financial results against industry benchmarks or specific comparable companies or projects. The transaction itself, a disposition for tax withholding, is a common practice for executives receiving equity compensation across various industries.

Related Party Transactions

• The disposition of shares by an executive to the issuer for tax withholding purposes is a common transaction related to executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related disposition of a small percentage of total outstanding shares. It reflects the vesting of executive equity, which is part of compensation structure.
• Employees: No direct impact indicated.
• Customers: No direct impact indicated.
• Suppliers: No direct impact indicated.
• Creditors: No direct impact indicated.

Next Steps

• The document does not outline any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

Integra LifeSciences, IART, SEC Form 4, Insider Trading, Stock Disposition, Executive Compensation, Tax Withholding, Lea Daniels Knight, Common Stock